Oleuropein / Dose Cancer Research Results

OLE, Oleuropein: Click to Expand ⟱

Features:

Oleocanthal is essentially found ONLY in: Fresh, unrefined extra-virgin olive oil (EVOO)
It is part of the pungent, throat-stinging phenolic fraction that disappears in refined oils.

Oleuropein (OLEU) — a secoiridoid polyphenol from olive leaf and olive fruit/extra-virgin olive oil; major in-vivo related phenolic is hydroxytyrosol (via hydrolysis/metabolism). Sources: olive leaf extract (standardized to oleuropein), EVOO phenolics.

Primary mechanisms (conceptual rank):
1) Redox modulation (ROS ↓ in normal tissue; stress/hormesis; NRF2 ↑ context-dependent)
2) Anti-inflammatory transcription suppression (NF-κB ↓)
3) Anti-proliferative signaling in cancer models (PI3K/AKT/mTOR ↓; MAPK modulation; apoptosis ↑; model-dependent)
4) Anti-angiogenic / hypoxia coupling (HIF-1α/VEGF ↓; model-dependent)

Bioavailability / PK relevance: Human data show absorption/metabolism after oral olive leaf extract; circulating forms are largely metabolites (and hydroxytyrosol-related), with limited free parent compound exposure. :contentReference[oaicite:0]{index=0}

In-vitro vs oral exposure: Many direct “anticancer” cytotoxic effects occur at micromolar concentrations that may exceed typical systemic exposure from supplements/foods (high concentration only for direct tumor cytotoxicity in many models). :contentReference[oaicite:1]{index=1}

Clinical evidence status: Nutraceutical/food bioactive with human data mainly for cardiometabolic/inflammation endpoints; oncology evidence largely preclinical/adjunct-hypothesis (no oncology approval).

Also available as a supplement usually labeled as Olive Leaf Extract. (20-50% concentrations)
- commonly used in CSC (Cancer Stem Cell) research.
Main CSC mechanisms:
-Inhibits Wnt/β-catenin — a core CSC survival pathway
-↓ALDH (Reduces ALDH-high CSC subpopulations)
-downregulates stemness geens: SOX2/OCT4/Nanog → reduced sphere formation/self-renewal.

Oleuropein — Cancer vs Normal Cell Pathway Map

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS	↑ or ↓ (dose-/model-dependent)	↓ (primary)	P/R	Redox reprogramming	Normal tissue: antioxidant/lipid-peroxidation reduction common. Cancer: higher exposures can induce stress/apoptosis; direction varies by model and co-stressors.
2	NF-κB / cytokine programs	↓	↓	R/G	Anti-inflammatory / anti-survival transcription	Commonly reported mechanism for oleuropein/olive phenolics. :contentReference[oaicite:3]{index=3}
3	NRF2 (protective vs resistance role)	↔ / ↑ (context-dependent)	↑	R/G	Antioxidant gene induction	NRF2 modulation is frequently discussed for olive polyphenols; in cancer contexts can be double-edged (cytoprotection/resistance). :contentReference[oaicite:4]{index=4}
4	PI3K/AKT/mTOR	↓ (model-dependent; high concentration only)	↔	R/G	Reduced anabolic survival signaling	Reported across cancer models and olive phenolic literature; translation depends on exposure. :contentReference[oaicite:5]{index=5}
5	Intrinsic apoptosis (Bax↑/Bcl-2↓; caspases)	↑ (model-dependent; high concentration only)	↔	R/G	Mitochondrial apoptosis	Common downstream endpoint in preclinical cancer work; often coupled to redox and PI3K/AKT shifts. :contentReference[oaicite:6]{index=6}
6	HIF-1α / VEGF (angiogenesis)	↓ (model-dependent)	↔	G	Reduced hypoxia-adaptation / vascular support	Typically secondary; varies strongly by model and readout.
7	Cell cycle checkpoints	↓ proliferation (model-dependent)	↔	G	Cytostatic growth restraint	Often reported as G0/G1 or G2/M arrest in vitro; exposure gap is common. :contentReference[oaicite:7]{index=7}
8	Ferroptosis	↔ (limited / context-dependent)	↔	R/G	Not canonical	Olive phenolics can influence lipid peroxidation, but a consistent oleuropein-driven ferroptosis program is not a core claim in the main reviews.
9	Ca²⁺ signaling	↔	↔	P/R	No primary role	Include only if a specific ER/mitochondrial stress model measures Ca²⁺ endpoints.
10	Clinical Translation Constraint	↓ (constraint)	↓ (constraint)	—	Metabolite-dominant exposure	Human absorption/metabolism exists, but many tumor-directed effects rely on higher in-vitro exposures; extract standardization and formulation matter. :contentReference[oaicite:8]{index=8}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr

Oleuropein — AD relevance: Oleuropein/olive leaf phenolics show neuroprotection in models via oxidative- and heat-shock/proteostasis stress responses, with reported reduction of Aβ and tau proteotoxicity in preclinical systems; human AD disease-modifying evidence is not established.

Primary mechanisms (conceptual rank):
1) ↓ Oxidative stress (ROS ↓; lipid peroxidation ↓; NRF2-linked defense ↑)
2) ↓ Neuroinflammation (NF-κB tone ↓)
3) Proteostasis support (heat-shock/stress-response pathways; context-dependent)
4) Aβ/tau proteotoxicity ↓ (preclinical)

Bioavailability / PK relevance: Human absorption/metabolism supports systemic exposure mainly as metabolites; brain relevance likely chronic/adaptive. :contentReference[oaicite:9]{index=9}

Clinical evidence status: Predominantly preclinical for AD mechanisms; limited AD-specific clinical endpoint evidence.

Oleuropein — AD / Neurodegeneration Pathway Map

Rank	Pathway / Axis	Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS / lipid peroxidation	↓	P/R	Reduced oxidative burden	Central neuroprotection rationale for olive polyphenols (includes oleuropein/hydroxytyrosol pathways). :contentReference[oaicite:11]{index=11}
2	NRF2 axis	↑ (context-dependent)	R/G	Stress-defense upshift	NRF2 modulation is repeatedly discussed for olive polyphenols in cognition-related health framing. :contentReference[oaicite:12]{index=12}
3	Neuroinflammation (NF-κB / cytokines)	↓	R/G	Lower inflammatory stress	Often paired with antioxidant effects; model-dependent magnitude.
4	Proteostasis / heat-shock stress responses	↑ (supportive)	R/G	Improved handling of misfolded proteins	Oleuropein-rich olive leaf extract reduced Aβ and tau proteotoxicity via oxidative/heat-shock stress regulation in a C. elegans model. :contentReference[oaicite:13]{index=13}
5	Aβ / tau proteotoxicity	↓ (preclinical)	G	Reduced pathology-linked toxicity	Evidence is stronger in models than in biomarker-confirmed human AD studies. :contentReference[oaicite:14]{index=14}
6	Ca²⁺ homeostasis / excitotoxic vulnerability	↔ / stabilized (indirect)	P/R	Supportive (secondary)	Typically secondary to mitochondrial/redox support unless a study explicitly measures Ca²⁺ endpoints.
7	Clinical Translation Constraint	↓ (constraint)	—	Preclinical-dominant AD evidence	Most AD-relevant mechanisms are model-based; human AD efficacy endpoints remain limited. :contentReference[oaicite:15]{index=15}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr

Dose, Dosage: Click to Expand ⟱

Source:

Type:

Drug dosage vs efficacy, and actual dosage number of research papers.

Scientific Papers found: Click to Expand⟱

4626-

OLE,

A Comprehensive Review on the Anti-Cancer Effects of Oleuropein

Review,

Var,

Risk↓, Dose↑, TumCP↓, NF-kB↓, COX2↓, Akt↓, P53↑, BAX↑, Bcl-2↓, HIF-1↓, ROS↑, HO-1↑, chemoP↑, TumCCA↑, FASN↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Functional Outcomes ⓘ

chemoP↑, 1, Risk↓, 1,
Total Targets: 15

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: Dose, Dosage

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:375  Target#:1114  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

Oleuropein / Dose Cancer Research Results

Oleuropein — Cancer vs Normal Cell Pathway Map

Oleuropein — AD / Neurodegeneration Pathway Map

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

Core Metabolism/Glycolysis ⓘ

Cell Death ⓘ

DNA Damage & Repair ⓘ

Cell Cycle & Senescence ⓘ

Migration ⓘ

Angiogenesis & Vasculature ⓘ

Immune & Inflammatory Signaling ⓘ

Drug Metabolism & Resistance ⓘ

Functional Outcomes ⓘ

Pathway results for Effect on Normal Cells:

Home Page